Cyclin 3D structures

3D Structures of Cyclin3D Structures of Cyclin

Updated on 16-June-2021

{"openlevels":0}

• CYCA
  • 7b5l – hCYCA + CDK2 + NEDD8 + cullin-1 + RBX1 + SKP1 + SKP2 + CKSHS1 + p27 + UBE2L3 + Ub + ARIH1 – human - Cryo EM
    
• CYCA2
  • 3my5, 2wpa, 2wxv, 2wih, 2wip, 3f5x, 3eoc, 3eid, 3ej1, 3dog, 3ddp, 3ddq, 3bht, 2v22, 2uue, 2i40, 2bkz, 2c5n, 2c5o, 2c5v, 2c5x, 2c5y, 2bpm, 2c4g, 1fvv, 2c6t – hCYCA2 +CDK2+inhibitor
    
  • 3bhu, 3bhv, 2uzd, 2uzb, 2uze, 2uzl, 2uzn, 2uzo, 2iw6, 2iw8, 2iw9, 2g9x, 1oi9, 1oiu, 1oiy, 1ogu, 1p5e, 1pkd, 1h1p, 1h1q, 1h1r, 1h1s, 4cfx, 4cfv, 4cfu, 4cfm, 5nev, 5nev, 5lmk, 5cyi - hCYCA2 +CDK2 T160P+inhibitor
    
  • 1fin, 5if1 - hCYCA2 +CDK2
    
  • 1vyw - hCYCA2 C-terminal 175-432 + hCDK2
    
  • 1jst, 3tnw, 6sg4 - hCYCA2 +CDK2 T160P
    
  • 1h24, 1h25, 1h26, 1h27, 1h28, 1gy3 - hCYCA2 +CDK2 T160P+peptide
    
  • 4bck, 4bcm, 4bcn, 4bco, 4bcp, 4bcq, 4cfn, 4cfw, 6gva, 6guf, 6gue, 6guc, 6gub - hCYCA2 +CDK2 T160P + inhibitor
    
  • 6ath - hCYCA2 +CDK2 T160P + cyclin-dependent kinase inhibitor
    
  • 4fx3 - hCYCA2 +CDK2 + inhibitor
    
  • 4eoi, 4eoj, 4eok, 4eol, 4eom, 4eon, 4eoo, 4eop, 4eoq, 4eor, 4eos, 6rij, 7ack - hCYCA2 C-terminal +CDK2 T160P + inhibitor
    
  • 2cjm - hCYCA2 +CDK2 T160P Y15P
    
  • 2cch - hCYCA2 +CDK2 T160P+ATP analog
    
  • 4i3z, 4ii5 - hCYCA2 +CDK2 T160P+ADP + Mg
    
  • 2cci - hCYCA2 +CDK2 T160P+CDC homolog
    
  • 2wma, 2wmb, 2x1n, 2wev, 2wfy, 2whb, 1okv, 1okw, 1ol1, 1ol2, 1urc, 1qmz, 3qhw, 6p3w - hCYCA2 +CDK2+peptide
    
  • 1jsu - hCYCA2 +CDK2 (mutant)+P27
    
  • 6q6g, 6q6h – hCYCA2 in APC/C-CDC20-CDK2-CKS2 complex – Cryo EM
    
  • 3qhr, 3khw - CYCA2 + P33 protein kinase + CDK2 peptide – mouse
• CYCA3
  • 1vin – CYCA3 - bovine
    
  • 1e9h – hCYCA3 +CDK2 T160P+inhibitor
    
• CYCB1 or G2/mitotic-specific CYCB1
  • 2b9r – hCYCB1 (mutant)
    
  • 2jgz - hCYCB1 + CDK2
    
  • 6gu4, 6gu3, 6gu2 – hCYCB1 + hCDK1 + inhibitor
    
  • 5hq0, 4yc3, 4y72 – hCYCB1 + hCDK1 + CDK regulatory subunit 2
    
  • 5lqf – hCYCB1 + hCDK1 + CDK regulatory subunit 2 + inhibitor
    
• CYCC
  • 3rgf, 4g6l – hCYCC + CDK8
    
  • 4f6s, 4f6u, 4f6w, 4f70, 4f7j, 4f7l, 4f7n, 4f7s, 5idp, 5idn, 5icp, 5i5z, 5hvy, 5hnb, 5hbj, 5hbh, 5hbe, 5fgk, 5cei, 5bnj, 5xqx, 5xs2, 6qtg, 6qtj, 6r3s, 6t41 – hCYCC + CDK8 + inhibitor
    
  • 6tpa – hCYCC + CDK8 + drug
    
• CYCD
  • 2w96, 2w99, 2w9f, 2w9z - hCYCD1 +CDK4 (mutant)
    
  • 6ei2 – hCYCD2 + HLA + microglobulin
    
  • 3g33 – hCYCD3 + CDK4
• CYCE
  • 1w98 – hCYCE1 + CDK2 T160P
    
  • 5l2w – hCYCE1 + CDK2 + drug
    
• CYCH
  • 1kxu, 1jkw – hCYCH
    
  • 6o9l – hCYCH in transcription preinitiation complex – Cryo EM
    
  • 6xbz – hCYCH + CDK7 + MAT1 – Cryo EM
    
  • 6xd3, 7b5o, 7b5q – hCYCH + CDK7 + MAT1 + inhibitor – Cryo EM
    
• CYCK
  • 2i53 – hCYCK N-terminal
    
  • 4un0 - hCYCK + CDK12 T160P
    
  • 4cxa - hCYCK + CDK12 T160P + AMPPNP
    
  • 5efq, 4nst - hCYCK + CDK13 T160P + ADP
    
  • 4un0, 5acb, 6b3e, 6ckx, 7nxj, 7nxk - hCYCK +CDK12 T160P + inhibitor
    
  • 6td3 - hCYCK +CDK12 T160P+ DDB1
    
• CYCT
  • 3blh - hCYCT1 +CDK9
    
  • 3blq - hCYCT1 +CDK9+ATP
    
  • 4imy, 4or5, 4ogr - hCYCT1 +CDK9 TPO160 +AMP + AF4/MRF2 family member 4
    
  • 5l1z - hCYCT1 +CDK9 TPO160 +AMP + AF4/MRF2 family member 4 + RNA
    
  • 6cyt - hCYCT1 +CDK9 TPO160 +AMP + AF4/MRF2 family member 4 + TAT + RNA
    
  • 3lq5, 3tn8, 3tnh, 3tni, 4bcf, 4bcg, 4bch, 4bci, 4bcj – hCYCT1 (mutant)+CDK9
    
  • 3blr - hCYCT1 +CDK9+inhibitor
    
  • 6gzh, 6z45 - hCYCT1 TPO160 +CDK9+inhibitor
    
  • 3my1, 4ec8, 4ec9 - hCYCT1 (mutant)+CDK9 TPO160 +inhibitor
    
  • 3mi9, 3mia - hCYCT1 +CDK9+protein TAT
    
  • 2w2h - CYCT1 +protein TAT + RNA – horse
    
  • 2ivx – hCYCT2 (mutant)
• CYC
  • 2pk9 – yCYC PHO80 +CDK PHO85 – yeast
    
  • 2pmi - yCYC PHO80 +CDK PHO85+ATPgS
• Viral CYC
  • 2euf, 2f2c, 2xo2, 1jow – V-CYC+hCDK6 – Herpesvirus
    
  • 1bu2 – V-CYC
    
  • 1xo2 - V-CYC + hCDK6 + inhibitor
    
  • 1g3n - V-CYC +hCDK6+CDK6 inhibitor
    
  • 1f5q - V-CYC g +hCDK2